You just read:

PTC Therapeutics Announces European Medicines Agency Validation of Marketing Authorization Application for Ataluren in Duchenne Muscular Dystrophy

News provided by

PTC Therapeutics, Inc.

Dec 06, 2012, 08:30 ET